Hot Pursuit     13-May-22
Alembic Pharmaceuticals Ltd gains for third straight session
Alembic Pharmaceuticals Ltd is quoting at Rs 742, up 1.98% on the day as on 12:49 IST on the NSE. The stock is down 20.98% in last one year as compared to a 9.14% jump in NIFTY and a 8.48% jump in the Nifty Pharma index.

Alembic Pharmaceuticals Ltd gained for a third straight session today. The stock is quoting at Rs 742, up 1.98% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.34% on the day, quoting at 16019.3. The Sensex is at 53598.52, up 1.26%. Alembic Pharmaceuticals Ltd has slipped around 4.28% in last one month.

Meanwhile, Nifty Pharma index of which Alembic Pharmaceuticals Ltd is a constituent, has slipped around 7.35% in last one month and is currently quoting at 12424.45, up 2.29% on the day. The volume in the stock stood at 2.55 lakh shares today, compared to the daily average of 3.01 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 749, up 2.93% on the day. Alembic Pharmaceuticals Ltd is down 20.98% in last one year as compared to a 9.14% jump in NIFTY and a 8.48% jump in the Nifty Pharma index.

The PE of the stock is 18.01 based on TTM earnings ending March 22.

Previous News
  Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 13-Aug-24   12:15 )
  Alembic Pharma gets US FDA nod for anticoagulant Dabigatran
 ( Hot Pursuit - 13-Aug-24   13:46 )
  Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr
 ( Hot Pursuit - 08-Aug-24   15:48 )
  Alembic Pharmaceuticals to discuss results
 ( Corporate News - 17-Oct-23   10:13 )
  Alembic receives final approval for Fluorouracil Injection
 ( Corporate News - 06-Mar-23   11:32 )
  Alembic Pharma gains on USFDA nod for Fluorouracil injection
 ( Hot Pursuit - 06-Mar-23   11:13 )
  Alembic Pharmaceuticals receives USFDA's tentative approval for Acalabrutinib Capsules
 ( Corporate News - 19-Jan-23   14:19 )
  Alembic Pharmaceuticals fixes record date for interim dividend
 ( Market Beat - Reports 27-Jul-22   14:22 )
  Alembic Pharma rises on USFDA nod for breast cancer drug
 ( Hot Pursuit - 01-Apr-24   13:52 )
  Alembic Pharmaceuticals receives USFDA approval for Doxycycline Capsules
 ( Corporate News - 28-Jun-24   13:38 )
  Alembic Pharmaceuticals Ltd down for fifth straight session
 ( Hot Pursuit - 01-Sep-22   13:35 )
Other Stories
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
  Real Estate stocks edge lower
  04-Oct-24   14:00
  Auto stocks edge lower
  04-Oct-24   14:00
  Utilties stocks edge lower
  04-Oct-24   14:00
  HDFC Bank Ltd down for fifth straight session
  04-Oct-24   13:35
Back Top